References

  1. Naldi L. Epidemiology of psoriasis.Curr Drug TargetsInflamm Allergy. 2004;3(2):121-8. PubMed | Google Scholar

  2. Mokhtar I. Étude épidémiologique observationnelle du psoriasis au Maghreb. Ann DermatolVénéréol. 2013; 140(S1): 10. PubMed | Google Scholar

  3. Lebwohl M. Psoriasis. Lancet. 2003; 361(9364):1197-204. PubMed | Google Scholar

  4. Bens G, Maccari F, Estève E. Psoriasis : une maladie systémique. Pres Med. 2012 ; 41(4):338-48. PubMed | Google Scholar

  5. Tervaert WE, Esseveld H. A study of the incidence of haemolytic streptococci in the throat of patients with psoriasis vulgaris, with reference to their role in the pathogenesis of the disease. Dermatologica.1970; 140(5):282-90. PubMed | Google Scholar

  6. Fry L, Baker BS. Triggering psoriasis: the role of infections and medications. Clin in Dermatol. 2007; 25(6):606-15. PubMed | Google Scholar

  7. Christophers E, Henseler T. Contrasting disease patterns in psoriasis and atopic dermatitis. Arch Dermatol Res. 1987;279:S48-S51. PubMed | Google Scholar

  8. Fahlén A, Engstrand L, Baker BS, Powles A, Fry L. Comparison of bacterial microbiota in skin biopsies from normal and psoriatic skin. Arch Dermatol Res. 2012;304(1):15-22. PubMed | Google Scholar

  9. Ong PY, Ohtake T, Brandt C, Strickland I, Boguniewicz M, Ganz T, Gallo RL, Leung DY. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med. 2002;347(15):1151-60. PubMed | Google Scholar

  10. Frohm M, Agerberth B, Ahangari G et al. The expression of the gene coding for the antibacterial peptide LL-37 is induced in human keratinocytes during inflammatory disorders. J Biol Chem. 1997;272(24):15258-63. PubMed | Google Scholar

  11. Grice EA, Kong HH, Conlan S, Denning CB, Davis J, Young J, Young AC, Bouffard GC, Blakesley RW, Murray PR, Green ED, Turner ML, Segre JA. Topographical and temporal diversity of the human skin microbiome.Science. 2009; 324(5931):1190-2. PubMed | Google Scholar

  12. Grice EA, Segre JA. The skin microbiome. Nat Rev Microbiol. 2011; 9(4):244-53. PubMed | Google Scholar

  13. Harder J, Bartels J, Christophers E, Schroder JM. A peptide antibiotic from human skin.Nature. 1997;387(6636):861. PubMed | Google Scholar

  14. Kluytmans J, van Belkum A, Verbrugh H. Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. Clin Microbiol Rev. 1997; 10(3): 505-20. PubMed | Google Scholar